首页> 外文期刊>Der Pharmacia Lettre >Development of uv spectrophotometric vierodta??s method for thesimultaneous estimation of abacavir and lamivudine in combinedtablet dosage form
【24h】

Development of uv spectrophotometric vierodta??s method for thesimultaneous estimation of abacavir and lamivudine in combinedtablet dosage form

机译:紫外分光光度法联合测定片剂组合形式阿巴卡韦和拉米夫定的方法

获取原文
           

摘要

Simple, accurate, precise, economical and reproducible analytical method have been developed for the simultaneous estimation of abacavir and lamivudine in pure bulk drug and in combined tablet dosage form by UV spectrophotometric Vierodt’s method. The stock solutions were prepared in mixture of acetonitrile and methanol (3:2) followed by the further required dilutions with distilled water. In proposed Vierodt’s method, the lmax for the estimation of abacavir and lamivudine were selected at 260 nm and 271 nm respectively. Linearity in concentration range of 5-25 mg/ ml by both the drugs was found. The method has estimated abacavir 100.01%, lamivudine 100.02% in the bulk drug and 99.86%, 99.82% of the both in tablets respectively. The results of analysis have been validated statistically and also by recovery studies. Thus the present study gives excellent method for the determination of both the drugs in combined tablet formulation.
机译:已开发出一种简单,准确,精确,经济且可重复的分析方法,用于通过紫外分光光度法Vierodt方法同时估算纯散装药物和组合片剂剂型中的阿巴卡韦和拉米夫定。在乙腈和甲醇(3:2)的混合物中制备储备溶液,然后用蒸馏水进一步稀释。在拟议的Vierodt方法中,估计阿巴卡韦和拉米夫定的lmax分别在260 nm和271 nm处选择。两种药物的浓度范围在5-25 mg / ml之间呈线性关系。该方法估计散装药物中阿巴卡韦的含量为100.01%,拉米夫定为100.02%,片剂中两者的含量分别为99.86%,99.82%。分析的结果已通过统计和恢复研究得到验证。因此,本研究为组合片剂中两种药物的测定提供了极好的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号